Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
Allied Biomedical Research Institute
mi
from
Miami, FL
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Allied Biomedical Research Institute
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
Miami Dade Medical Research Institute
mi
from
Miami, FL
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Miami Dade Medical Research Institute
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
PharmaSeek LLC (DMI Research)
mi
from
Pinellas Park, FL
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
PharmaSeek LLC (DMI Research)
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
iResearch Atlanta LLC
mi
from
Decatur, GA
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
iResearch Atlanta LLC
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
RTR Medical Group
mi
from
Savannah, GA
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
RTR Medical Group
mi
from
Savannah, GA
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
Mid-Atlantic Geriatric/ARC
mi
from
Manchester Township, NJ
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Mid-Atlantic Geriatric/ARC
mi
from
Manchester Township, NJ
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
Roper St. Francis Healthcare
mi
from
Charleston, SC
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Roper St. Francis Healthcare
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
Wesley Neurology Clinic
mi
from
Cordova, TN
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Wesley Neurology Clinic
mi
from
Cordova, TN
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
Howard University
mi
from
Washington, D.C.,
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Howard University
mi
from
Washington, D.C.,
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
The Neurocognitive Institute, LLC
mi
from
Mount Arlington, NJ
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
The Neurocognitive Institute, LLC
mi
from
Mount Arlington, NJ
Click here to add this to my saved trials
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated:  8/1/2017
Hospital General de Elche
mi
from
Elche,
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD
Status: Enrolling
Updated: 8/1/2017
Hospital General de Elche
mi
from
Elche,
Click here to add this to my saved trials
CPC-201 Alzheimer's Disease Type Dementia: PET Study
Phase II, Modified Single-Blind, Sequential Treatment, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Cerebral Efficacy of CPC-201 in Patients With Alzheimer's Disease Type Dementia: PET Study
Status: Enrolling
Updated:  8/8/2017
Henry Ford Health System--West Bloomfield Hospital
mi
from
West Bloomfield Township, MI
CPC-201 Alzheimer's Disease Type Dementia: PET Study
Phase II, Modified Single-Blind, Sequential Treatment, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Cerebral Efficacy of CPC-201 in Patients With Alzheimer's Disease Type Dementia: PET Study
Status: Enrolling
Updated: 8/8/2017
Henry Ford Health System--West Bloomfield Hospital
mi
from
West Bloomfield Township, MI
Click here to add this to my saved trials
Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services
Status: Enrolling
Updated:  9/14/2017
Univ of Washington
mi
from
Seattle, WA
Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services
Status: Enrolling
Updated: 9/14/2017
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Preliminary Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Bryostatin 1 in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  10/3/2017
California Clinical Trials Medical Center
mi
from
Glendale, CA
Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Preliminary Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Bryostatin 1 in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 10/3/2017
California Clinical Trials Medical Center
mi
from
Glendale, CA
Click here to add this to my saved trials
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain
Phase 0 Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Progressive Supranuclear Palsy or Alzheimer's Disease Compared to Healthy Volunteers
Status: Enrolling
Updated:  10/5/2017
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain
Phase 0 Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Progressive Supranuclear Palsy or Alzheimer's Disease Compared to Healthy Volunteers
Status: Enrolling
Updated: 10/5/2017
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
Click here to add this to my saved trials
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Mild-To-Moderate Alzheimer's Disease
Status: Enrolling
Updated:  10/9/2017
Stanford University
mi
from
Stanford, CA
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Mild-To-Moderate Alzheimer's Disease
Status: Enrolling
Updated: 10/9/2017
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
mi
from
Palo Alto, CA
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
mi
from
Deerfield Beach, FL
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
mi
from
Hialeah, FL
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
mi
from
Melbourne, FL
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
mi
from
Melbourne, FL
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
mi
from
Plantation, FL
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
mi
from
Plantation, FL
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
mi
from
Tampa, FL
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
mi
from
Centerville, OH
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
mi
from
Centerville, OH
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
mi
from
Tulsa, OK
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
mi
from
Nashville, TN
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated:  10/9/2017
GSK Investigational Site
mi
from
Graz-Eggenberg,
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
Status: Enrolling
Updated: 10/9/2017
GSK Investigational Site
mi
from
Graz-Eggenberg,
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Orange, CA
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
San Francisco, CA
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Boca Raton, FL
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Miami Beach, FL
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Miami, FL
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Port Charlotte, FL
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
West Palm Beach, FL
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Snellville, GA
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Snellville, GA
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Saint Louis, MO
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Omaha, NE
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Long Branch, NJ
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Long Branch, NJ
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
mi
from
Manchester Township, NJ
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
mi
from
Manchester Township, NJ
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Toms River, NJ
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Columbus, OH
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Dayton, OH
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Greensburg, PA
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Greensburg, PA
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Nashville, TN
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Austin, TX
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
mi
from
Houston, TX
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials